Crossref
Pevifoscorvir sodium (ALG-000184): advancing towards a novel therapeutic for chronic hepatitis B virus
Translational Gastroenterology and Hepatology · 2026-11 · 11 · 129-129
DOI: 10.21037/tgh-2026-0159 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Gastroenterology and Hepatology, 2026-11. Verfasst von Kyongmin Kim und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kim, K., & Sajjad, M. A. (2026). Pevifoscorvir sodium (ALG-000184): advancing towards a novel therapeutic for chronic hepatitis B virus. Translational Gastroenterology and Hepatology, 11, 129-129. https://doi.org/10.21037/tgh-2026-0159
Vancouver
Kim K, Sajjad MA. Pevifoscorvir sodium (ALG-000184): advancing towards a novel therapeutic for chronic hepatitis B virus. Translational Gastroenterology and Hepatology. 2026;11:129-129. doi:10.21037/tgh-2026-0159
BibTeX
@article{Kim2026,
author = {Kim, Kyongmin and Sajjad, Muhammad Azhar},
title = {Pevifoscorvir sodium (ALG-000184): advancing towards a novel therapeutic for chronic hepatitis B virus},
journal = {Translational Gastroenterology and Hepatology},
year = {2026},
volume = {11},
pages = {129--129},
doi = {10.21037/tgh-2026-0159}
}
EUVIMED